Stay updated on Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page shows a new revision tag, updating from v3.6.2 to v3.6.3 to reflect a minor page update.
    Difference
    0.0%
    Check dated 2026-07-06T18:17:55.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.6.2 tag appears on the page, replacing the previous v3.6.0 tag. This reflects a behind-the-scenes update to the page version without altering the displayed study details.
    Difference
    0.0%
    Check dated 2026-06-29T14:47:27.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now shows a recruitment closure note ('No longer looking for participants'), and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The Study Details heading formatting changes from 'Intervention / Treatment' to 'Intervention/Treatment' to reflect a consistency update.
    Difference
    0.3%
    Check dated 2026-06-15T08:34:38.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor site build version bump.
    Difference
    0.0%
    Check dated 2026-06-08T03:55:10.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4. This represents a minor update to the page's revision history rather than a substantive content change.
    Difference
    0.0%
    Check dated 2026-05-17T09:42:07.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page footer revision marker was updated to **Revision: v3.5.3** (from **v3.5.2**), reflecting an interface/version change rather than any study-record information.
    Difference
    0.0%
    Check dated 2026-04-25T17:47:34.000Z thumbnail image

Stay in the know with updates to Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.